Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NYMXFNYMXF
20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Nymox Pharmaceutical Corp.

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of NYMXF (Nymox Pharmaceutical Corp.), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$350,000

Total Shares Change

-268,042

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$0.52
0
2023-Q2
Unchanged
50,678
0.0%
$9,6280.0%$0.22
0
2023-Q1
Unchanged
50,678
0.0%
$17,2300.0%$0.38
0
2022-Q4
Unchanged
50,678
0.0%
$15,0000.0%$0.32
0
2022-Q3
Unchanged
50,678
0.0%
$21,0000.0%$0.37
0
2022-Q2
Unchanged
50,678
0.0%
$22,0000.0%$0.41
0
2022-Q1
Unchanged
50,678
0.0%
$63,0000.0%$1.24
0
2021-Q4
Decreased
50,678
-0.1%
$65,0000.0%$0.95
0
2021-Q3
Increased
50,731
+21.8%
$104,0000.0%$2.01
18
2021-Q2
Decreased
41,645
-86.3%
$65,0000.0%$1.58
0
2021-Q1
Increased
303,055
+1.1%
$672,0000.0%$2.22
25
2020-Q4
Increased
299,793
+0.9%
$743,0000.0%$2.53
25
2020-Q3
Increased
297,236
+4.4%
$731,0000.0%$2.60
26
2020-Q2
Increased
284,830
+584.8%
$1M0.0%$3.52
40
2020-Q1
Decreased
41,592
-20.5%
$97,0000.0%$2.18
0
2019-Q4
Increased
52,344
+100.0%
$114,0000.0%$2.25
24
2019-Q3
Decreased
26,172
-3.1%
$48,0000.0%$1.89
0
2019-Q2
Decreased
27,005
-81.9%
$39,0000.0%$1.45
0
2019-Q1
Decreased
149,354
-44.3%
$294,0000.0%$1.97
0
2018-Q4
New
268,042
-
$350,0000.0%$1.42
33

Other major holders of NYMXF: BNP PARIBAS FINANCIAL MARKETS, Federation des caisses Desjardins du Quebec, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used